AnalystsLi WatsekLi Watsek's Stock Forecasts
AnalystsLi Watsek
Sectors:
Industries:
Analyst Ranking
Bottom 2%
#5435 out of 5510 analysts
Average Return
-10.57%
Win Rate
43%43 out of 100
Risk vs Reward
Poor
Good
Li Watsek's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Corvus Pharmaceuticals IncCRVS | +145.73% | $1.64 | $4.03 | 2023-09-07 - 2024-09-06 | Strong Buy |
Ascendis Pharma AASND | +94.25% | $69.96 | $135.90 | 2023-04-28 - 2024-04-26 | Strong Buy |
Kura Oncology IncKURA | +93.67% | $9.96 | $19.29 | 2023-09-07 - 2024-09-06 | Strong Buy |
Kura Oncology IncKURA | +90.28% | $11.01 | $20.95 | 2023-07-21 - 2024-07-19 | Strong Buy |
Kura Oncology IncKURA | +90.23% | $5.73 | $10.90 | 2025-06-26 - 2026-06-26 | Strong Buy |
Li Watsek Analyst Color
Get additional color on Li Watsek's coverage of popular stocks
Li Watsek's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nuvation Bio IncNUVB | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 25 days ago |
Replimune Group IncREPL | 4 | Strong Buy | N/A | N/A | Upgrades | 2 months ago |
Immuneering CorpIMRX | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 months ago |
Adlai Nortye Group LtdANL | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 3 months ago |
Zai Lab LtdZLAB | 2 | Strong Buy | $37.00 | +50.53% | Maintains | 7 months ago |
Tyra Biosciences IncTYRA | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 7 months ago |
Arrivent Biopharma IncAVBP | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 9 months ago |
Compass Therapeutics IncCMPX | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 9 months ago |
Ascendis Pharma AASND | 20 | Strong Buy | $254.00 | -4.12% | Maintains | a year ago |
Context Therapeutics IncCNTX | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | a year ago |
Ideaya Biosciences IncIDYA | 3 | Strong Buy | N/A | N/A | Reiterates | a year ago |
Kura Oncology IncKURA | 11 | Strong Buy | N/A | N/A | Reiterates | a year ago |
Acrivon Therapeutics IncACRV | 2 | Strong Buy | N/A | N/A | Reiterates | a year ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Arvinas IncARVN | 5 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Alx Oncology Holdings IncALXO | 7 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Arcus Biosciences IncRCUS | 4 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Y Mabs Therapeutics IncYMAB | 2 | Strong Buy | $20.00 | N/A | Reiterates | 2 years ago |
Bicycle Therapeutics PLCBCYC | 5 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Curis IncCRIS | 1 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Vincerx Pharma IncVINC | 5 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Corvus Pharmaceuticals IncCRVS | 5 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Sellas Life Sciences Group IncSLS | 3 | Strong Buy | $3.00 | N/A | Reiterates | 3 years ago |
Affimed NvAFMDQ | 4 | Strong Buy | $70.00 | N/A | Reiterates | 3 years ago |
Alpha Compute CorpALP | 3 | Strong Buy | $220.00 | N/A | Reiterates | 3 years ago |
Oncternal Therapeutics IncONCT | 3 | Hold | $26.00 | N/A | Reiterates | 3 years ago |
Fate Therapeutics IncFATE | 3 | Hold | $5.00 | N/A | Reiterates | 3 years ago |
Aptose Biosciences IncAPTOF | 2 | Strong Buy | $1,140.00 | N/A | Reiterates | 3 years ago |
Nkarta IncNKTX | 1 | Strong Buy | $38.00 | N/A | Maintains | 4 years ago |
Global Blood Therapeutics IncGBT | 2 | Hold | $68.50 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.